Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFoundation for the National Institutes of Health

About this trial

The purpose of this study is to evaluate body composition across a variety of medical, professional, and commercial devices, including: bioelectrical impedance analysis (BIA) devices, 3-dimensional optical imaging (3DO), manual anthropometry measurements, dual-energy X-ray absorptiometry (DXA), magnetic resonance imaging (MRI), and blood tests. The secondary study purpose is to compare body composition measurements from BIA devices, 3DO, and manual anthropometry measurements within a 1-week period for a subset of the study population.

The study plans to enroll 300 healthy (having no life-threatening conditions or diseases; male and female) participants, 18 years of age or older.

Eligibility criteria

Qualifiers

Being willing to provide written informed consent prior to participation Being willing to complete the study visits and comply with the study procedures

Being willing to travel to the various study locations for On-site, DXA, MRI, and Phlebotomy visits

Being willing to change into appropriate form-fitting clothing for 3DO assessments and/or appropriate gowns for DXA and MRI imaging

Must have a BMI within the range of 18.5 - 45 kg/m2

Disqualifiers

Being pregnant or attempting to become pregnant

Having medical implants, such as a pacemaker or metal joint replacements, or other metal implants contraindicated for MRI

Cosmetic implants, such as breast implants

Having a height greater than DXA scanning limit (77 inches)

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Foundation for the National Institutes of Health

Lead sponsor

Exponent, Inc.

Collaborator

Pennington Biomedical Research Center

Collaborator

Texas Tech University

Collaborator